Recurrent Ischemic Stroke-A Systematic Review and Meta-Analysis

被引:79
|
作者
Kolmos, Mia [1 ]
Christoffersen, Laura [2 ]
Kruuse, Christina [1 ]
机构
[1] Herlev Gentofte Hosp, Dept Neurol, Neurovasc Res Unit, Hellerup, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
来源
关键词
Stroke recurrence; TOAST-criteria; Stroke subtype; Secondary prevention; WHITE-MATTER LESIONS; SMALL VESSEL DISEASE; LONG-TERM SURVIVAL; HEMORRHAGIC STROKE; DIFFERENT SUBTYPES; 1ST-EVER STROKE; GLOBAL BURDEN; RISK-FACTORS; 1ST YEAR; LEUKOARAIOSIS;
D O I
10.1016/j.jstrokecerebrovasdis.2021.105935
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objectives: Recurrent stroke remains a challenge though secondary prevention is initiated immediately post-stroke. Stroke subtype may determine the risk of recurrent stroke and require specific preventive measures. We aimed to identify subtype -specific stroke recurrence and associated risk factors over time. Methods and materials: A systematic review was performed using PubMed and Embase for studies including adults >18 years, first-ever ischemic stroke in population-based observational studies or registries, documented TOAST-criteria and minimum 1-year follow-up. Meta-analysis on stroke recurrence rate was performed. Final search: November 2019. Results: The search retrieved 26 studies (between 1997 and 2019). Stroke recurrence rate ranged from 5.7% to 51.3%. Recurrent stroke was most frequent in large artery atherosclerosis (LAA) and cardioembolic (CE) stroke with recurrent stroke similar to index stroke subtype. We identified a lower recurrence rate for small vessel occlusion (SVO) stroke with recurrence frequently of another stroke subtype. Based on a meta-analysis the summary proportion recurrence rate of recurrent stroke in studies using TOAST-criteria = 0.12 and = 0.14 in studies using TOAST like criteria. Hypertension, diabetes mellitus, atrial fibrillation previous transient ischemic attack, and high stroke severity were independent risk factors for recurrence. Conclusion: Stroke recurrence rates seem unchanged over time despite the use of secondary prevention. The highest recurrence rate is in LAA and CE stroke eliciting same subtype recurrent stroke. A lower recurrence rate is seen with SVO stroke with a more diverse recurrence pattern. Extensive workup is important in all stroke subtypes including SVO stroke. Future research needs to identify better preventive treatment and improve compliance to risk factor prevention to reduce stroke recurrence.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Therapeutic Hypothermia in Acute Ischemic Stroke-a Systematic Review and Meta-Analysis
    Kuczynski, Andrea M.
    Marzoughi, Sina
    Al Sultan, Abdulaziz S.
    Colbourne, Frederick
    Menon, Bijoy K.
    van Es, Adriaan C. G. M.
    Berez, Aaron L.
    Goyal, Mayank
    Demchuk, Andrew M.
    Almekhlafi, Mohammed A.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2020, 20 (05)
  • [2] Antiphospholipid Antibody and Recurrent Ischemic Stroke A Systematic Review and Meta-Analysis
    Kim, Yerim
    Kim, Soo Young
    [J]. STROKE, 2020, 51 (12) : 3728 - 3732
  • [3] Antiphospholipid Syndrome and Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis
    Kim, Yerim
    Kim, Soo Young
    [J]. CEREBROVASCULAR DISEASES, 2020, 49 (SUPPL 1) : 130 - 130
  • [4] Clinical and Imaging Predictors of Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis
    Kauw, Frans
    Takx, Richard A. P.
    de Jong, Hugo W. A. M.
    Velthuis, Birgitta K.
    Kappelle, L. Jaap
    Dankbaar, Jan. W.
    [J]. CEREBROVASCULAR DISEASES, 2018, 45 (5-6) : 279 - 287
  • [5] Cerebral Microbleeds and Recurrent Stroke Risk Systematic Review and Meta-Analysis of Prospective Ischemic Stroke and Transient Ischemic Attack Cohorts
    Charidimou, Andreas
    Kakar, Puneet
    Fox, Zoe
    Werring, David J.
    [J]. STROKE, 2013, 44 (04) : 995 - +
  • [6] Edaravone for Acute Ischemic Stroke: A Systematic Review and Meta-analysis
    Zhao, Kun
    Li, Guang-zong
    Nie, Liu-yan
    Ye, Xiang-ming
    Zhu, Gen-ying
    [J]. CLINICAL THERAPEUTICS, 2022, 44 (12) : e29 - e38
  • [7] Ancrod for acute ischemic stroke: A systematic review and meta-analysis
    Demaerschalk, Bart M.
    Bobrow, Bentley
    [J]. STROKE, 2007, 38 (02) : 506 - 506
  • [8] Tirofiban for acute ischemic stroke: systematic review and meta-analysis
    Gong, Jinhong
    Shang, Jingjing
    Yu, Hai
    Wan, Qian
    Su, Dan
    Sun, Zhiqiang
    Liu, Guangjun
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (04) : 475 - 481
  • [9] Tirofiban for acute ischemic stroke: systematic review and meta-analysis
    Jinhong Gong
    Jingjing Shang
    Hai Yu
    Qian Wan
    Dan Su
    Zhiqiang Sun
    Guangjun Liu
    [J]. European Journal of Clinical Pharmacology, 2020, 76 : 475 - 481
  • [10] The incidence of pediatric ischemic stroke: A systematic review and meta-analysis
    Gao, Lan
    Lim, Megumi
    Nguyen, Dieu
    Bowe, Steven
    MacKay, Mark T.
    Stojanovski, Belinda
    Moodie, Marj
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (07) : 765 - 772